Cholestyramine and Pentam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cholestyramine (cholestyramine) and Pentam (pentamidine isethionate). Common drug interactions include pyrexia among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Cholestyramine and Pentam. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Cholestyramine?

Cholestyramine has active ingredients of cholestyramine. It is often used in diarrhea. eHealthMe is studying from 9,893 Cholestyramine users. Check the latest studies of Cholestyramine.

What is Pentam?

Pentam has active ingredients of pentamidine isethionate. eHealthMe is studying from 5,686 Pentam users. Check the latest studies of Pentam.

On Jul, 11, 2026

11 people who take Cholestyramine and Pentam together, and have interactions are studied.

Cholestyramine and Pentam drug interactions.

What are the common drug interactions of Cholestyramine and Pentam, by gender? *:

female:

Pyrexia (fever)
Rash
Rash macular (small, flat red spots)
Thrombocytopenia (decrease of platelets in blood)
Plasma cell myeloma (cancer that begins in plasma cells)
Acute graft versus host disease in intestine (acute complication in intestine following an allogeneic tissue/blood transplant)
Acute graft versus host disease in liver (acute complication in liver following an allogeneic tissue/blood transplant)
Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
Cholecystitis acute (rapid infection of gallbladder)
Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)

male:

Asthenia (weakness)
Bone marrow disorder
Fatigue (feeling of tiredness)
Tremor (trembling or shaking movements in one or more parts of your body)
White blood cell count decreased

What are the common drug interactions of Cholestyramine and Pentam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Acute graft versus host disease in intestine (acute complication in intestine following an allogeneic tissue/blood transplant)
Acute graft versus host disease in liver (acute complication in liver following an allogeneic tissue/blood transplant)
Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
Cholecystitis acute (rapid infection of gallbladder)
Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
Dyspnoea (difficult or laboured respiration)
Encephalitis cytomegalovirus (inflammation of the brain due to cytomegalovirus)
Hypotension (abnormally low blood pressure)
Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
Wheezing (a high-pitched whistling sound made while you breath)

60+:

Fatigue (feeling of tiredness)
Abdominal discomfort
Asthenia (weakness)
Bone marrow disorder
Tremor (trembling or shaking movements in one or more parts of your body)
White blood cell count decreased
Abdominal distension
Constipation
Contusion (a type of hematoma of tissue in which capillaries)
Pyrexia (fever)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 9 people, 81.82%

* Approximation only. Some reports may have incomplete information.

Do you take Cholestyramine and Pentam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously